AHR and neoplasm: For example, the AhR-target PARP7 (product of the gene TIPARP), can directly suppress STING activity by facilitating the degradation of TBK1, a key downstream effector kinase of STING, thereby suppressing IFN-I expression and subsequent anti-tumor immunity39.